AIHealthcare

Paradigm Health is a privately held healthcare technology company developing an AI-native clinical research platform. Its software integrates with healthcare-provider systems and uses AI-enabled patient matching, clinical-trial feasibility, data collection, and workflow automation to connect patients and providers with biopharmaceutical sponsors and clinical trials. The company was incubated by ARCH Venture Partners and, following its acquisition of Flatiron Health’s Clinical Research business, reports a major oncology research network while expanding into neuroscience, cardiovascular, metabolic, and other therapeutic areas. Its stated market position is as an infrastructure and execution partner for health systems, biopharma companies, and clinical research organizations seeking faster, broader, and more equitable trial access.